Research Papers

13 of 2513 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Reduction of post injury neointima formation due to 17beta-estradiol and phytoestrogen treatment is not influenced by t…
Finking G; Lenz C; Schochat T; Hanke H.
BMC Cardiovasc Disord (Unknown)
Published: 2002
2/6 Transparent
Funding Declared
Expression of TGF-beta1 and beta3 but not apoptosis factors relates to flow-induced aortic enlargement.
Xu C; Lee S; Shu C; Masuda H; Zarins CK.
BMC Cardiovasc Disord (Unknown)
Published: 2002
2/6 Transparent
Funding Declared
Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.
Majamaa-Voltti K; Peuhkurinen K; Kortelainen ML; Hassinen IE; Majamaa K.
BMC Cardiovasc Disord (Unknown)
Published: 2002
2/6 Transparent
Funding Declared
Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postisch…
Bertuglia S; Giusti A.
BMC Cardiovasc Disord (Unknown)
Published: 2002
1/6 Transparent
Funding Declared
Diagnostic strategies for C-reactive protein.
Riese H; Vrijkotte TG; Meijer P; Kluft C; de Geus EJ.
BMC Cardiovasc Disord (Unknown)
Published: 2002
2/6 Transparent
Funding Declared
T Wave Alternans in high arrhythmic risk patients: analysis in time and frequency domains: a pilot study.
Hunt AC.
BMC Cardiovasc Disord (Unknown)
Published: 2002
1/6 Transparent
Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation.
Ruigómez A; Johansson S; Wallander MA; García Rodríguez LA.
BMC Cardiovasc Disord (Unknown)
Published: 2002
2/6 Transparent
Funding Declared
A comparison of the illness beliefs of people with angina and their peers: a questionnaire study.
Furze G; Roebuck A; Bull P; Lewin RJ; Thompson DR.
BMC Cardiovasc Disord (Unknown)
Published: 2002
1/6 Transparent
Arterial wall properties and Womersley flow in Fabry disease.
Moore DF; Altarescu G; Pursley R; Campia U; Panza JA; Dimitriadis E; Schiffmann R.
BMC Cardiovasc Disord (Unknown)
Published: 2002
2/6 Transparent
Funding Declared
Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats.
Theuer J; Dechend R; Muller DN; Park JK; Fiebeler A; Barta P; Ganten D; Haller H; Dietz R; Luft FC.
BMC Cardiovasc Disord (Unknown)
Published: 2002
1/6 Transparent
Funding Declared
Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: th…
Voisard R; Kucharczyk E; Deininger U; Baur R; Hombach V.
BMC Cardiovasc Disord (Unknown)
Published: 2002
5-fluorouracil-induced cardiotoxicity mimicking myocardial infarction: a case report.
McGlinchey PG; Webb ST; Campbell NP.
BMC Cardiovasc Disord (Unknown)
Published: 2001
1/6 Transparent
Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease.
Nicholson T; McGuire A; Milne R.
BMC Cardiovasc Disord (Unknown)
Published: 2001
2/6 Transparent
Funding Declared